Orange Book product · Brand (NDA)

CORLANOR

IVABRADINE HYDROCHLORIDE

Brand (NDA)NDA 206143DISCN AMGEN INC

Apr 15, 2015

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
Apr 15, 2015
11 yr 4 mo ago
Patent 7361649 expires
Listed drug substance patent expiration.
Feb 22, 2026
4 mo ago
Patent 7361650 expires
Listed drug substance patent expiration.
Feb 22, 2026
4 mo ago
Patent 7879842 expires
Listed drug substance patent expiration.
Feb 22, 2026
4 mo ago
Today
Patent 7361649*PED expires
Listed listed patent expiration.
Aug 22, 2026
in 2 mo
Patent 7361650*PED expires
Listed listed patent expiration.
Aug 22, 2026
in 2 mo
Patent 7879842*PED expires
Listed listed patent expiration.
Aug 22, 2026
in 2 mo
Patent 7867996 expires
Listed drug substance patent expiration.
Dec 12, 2026
in 6 mo
Patent 7867996*PED expires
Listed listed patent expiration.
Jun 12, 2027
in 1 yr

Active ingredient

IVABRADINE HYDROCHLORIDE

Strength

EQ 5MG BASE

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 206143

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
7361649	Feb 22, 2026	4 mo ago	SubstanceProductU-1694
7361650	Feb 22, 2026	4 mo ago	SubstanceProductU-1694
7879842	Feb 22, 2026	4 mo ago	SubstanceProductU-1694
7361649*PED	Aug 22, 2026	in 2 mo
7361650*PED	Aug 22, 2026	in 2 mo
7879842*PED	Aug 22, 2026	in 2 mo
7867996	Dec 12, 2026	in 6 mo	SubstanceProductU-1694
7867996*PED	Jun 12, 2027	in 1 yr